Partnerships

Business Development Partnerships

We are actively seeking strategic partners that align with our vision.

Research
Partnerships

We are actively seeking research and licensing partners and research collaborations to fully leverage the experience of our team in clinical development and strategy across atopic, respiratory, and immunoe-inflammatory diseases. These may include small molecules to augment the transformational potential of our KINect® platform for drug discovery, and biologic product candidates such as monoclonal and bi-specific antibodies. Specific areas of interest include:

  • Kinases inhibitors for autoimmune diseases, such as rheumatoid arthritis, chronic inflammation disease (e.g. inflammatory bowel disease), autoinflammatory diseases (e.g. CAPS, Stills Disease), and cancer. 
  • New therapeutic applications for our cysteinome-targeted chemical library representing 60% of the kinome.
  • Biologic product candidates targeting validated pathways in immune-inflammatory diseases, including in respiratory and dermatology settings

Learn more about the KINect® platform

If you are interested in participating in an investigator-initiated study, find out more.